Summary
Dalbavancin is a new antibiotic agent active against gram-positive pathogens that is effective for the treatment of acute bacterial skin and skin structure infection, according to results from the DISCOVER 1 and DISCOVER 2 trials. Results from a new subgroup analysis show that dalbavancin is effective for this type of infection regardless of weight category.
- dalbavancin
- vancomycin
- linezolid
- obesity
- overweight
- normal-weight
- acute bacterial skin and skin structure infections
- infectious diseases clinical trials
- viral infections
- © 2015 SAGE Publications
Tools
Dalbavancin Effective Treatment for Skin Infection Regardless of Weight Category
Permalink:
Table of contents
Cited By...
- No citing articles found.